Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia

Published:2006-05-17 Issue:11 Volume:37 Page:997-1001
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Trifilio S,Gordon L,Singhal S,Tallman M,Evens A,Rashid K,Fishman M,Masino K,Pi J,Mehta J

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705379.pdf

Reference13 articles.

1. Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, Schreiber MJ . Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med 2004; 116: 546–554.

2. Smith GW, Wright V . Allopurinol. Br J Clin Pract 1987; 41: 710–711.

3. Wu XW, Lee CC, Muzny DM, Caskey CT . Urate oxidase: primary structure and evolutionary implications. Proc Natl Acad Sci USA 1989; 86: 9412–9416.

4. Leach M, Parsons RM, Reilly JT, Winfield DA . Efficacy of urate oxidase (uricozyme) in tumour lysis induced urate nephropathy. Clin Lab Haematol 1998; 20: 169–172.

5. Bayol A, Capdevielle J, Malazzi P, Buzy A, Bonnet MC, Colloc'h N et al. Modification of a reactive cysteine explains differences between rasburicase and uricozyme, a natural Aspergillus flavus uricase. Biotechnol Appl Biochem 2002; 36: 21–31.

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumour lysis syndrome;Nature Reviews Disease Primers;2024-08-22

2. Review of Hematological and Oncological Emergencies;Advanced Emergency Nursing Journal;2022-04

3. A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia;Leukemia Research;2021-08

4. Efficacy of Single Low-Dose Rasburicase in Management of Tumor Lysis Syndrome in Leukemia and Lymphoma Patients;Clinical Lymphoma Myeloma and Leukemia;2021-01

5. Assessment of rasburicase utilization for tumor lysis syndrome management in pediatric and adult patients in the inpatient and outpatient settings;Journal of Oncology Pharmacy Practice;2020-07-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3